Fatigue With Rheumatoid Arthritis Tied to Disease Activity, Education Level
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 26, 2024 -- The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Brief Fatigue Inventory (BFI-C) scores show consistency in assessing fatigue with rheumatoid arthritis (RA), according to a study published online June 14 in Immunity, Inflammation and Disease.
Jun Zhou, from the Affiliated Suqian First People's Hospital of Nanjing Medical University in China, and colleagues assessed fatigue with RA by two scales and validated their consistency. Analysis included 160 patients with RA and 60 healthy controls.
The researchers found that the BRAF-MDQ and BFI-C scores were significantly elevated in RA patients versus healthy controls. There was a positive and significant correlation between BRAF-MDQ global fatigue score and BFI-C global fatigue score in both RA patients (r = 0.669) and healthy controls (r = 0.527). There was a high consistency between BRAF-MDQ and BFI-C global fatigue scores in RA patients (W = 0.759) and healthy controls (W = 0.933) using the Kendall's tau-b test. Higher education level (В = −4.547) and swollen joint count (В = 1.965) independently were associated with BRAF-MDQ global fatigue score. Higher education level (В = −0.613) and clinical disease activity index (В = 0.053) independently linked with BFI-C global fatigue score.
"Exploring the risk factors of fatigue for early management is of great significance for the treatment of RA patients," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-27 03:15
Read more
- Transitioning to E-Cigarettes Aids Resolution of Respiratory Symptoms
- Racial, Gender, Socioeconomic Disparities Seen in Teen Alcohol, Drug Screening
- AHA: Obesity-Linked Ischemic Heart Disease Mortality Increasing in U.S.
- 1 in 5 Americans' Drinking Water Tainted With PFAS Chemicals
- Native Hawaiian and Pacific Islander Adults Have High CVD Mortality
- A Cancer Diagnosis Takes Devastating Toll on Family Finances
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions